Patents by Inventor Martin J. Griffin

Martin J. Griffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Self-emulsifying drug delivery system
    Patent number: 7226932
    Abstract: Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the formulation includes an emulsifier, an oil and an solubilizer. Alternatively, the formulation includes an aqueous solution of solubilizer.
    Type: Grant
    Filed: April 29, 2003
    Date of Patent: June 5, 2007
    Assignee: G.D. Searle LLC
    Inventors: Rajeev Gokhale, Martin J. Griffin, James E. Truelove, James C. Stolzenbach, Aziz Karim, Ajit K. Roy
  • Self-emulsifying drug delivery system
    Publication number: 20040048934
    Abstract: Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the formulation includes an emulsifier, an oil and an solubilizer. Alternatively, the formulation includes an aqueous solution of solubilizer.
    Type: Application
    Filed: April 29, 2003
    Publication date: March 11, 2004
    Applicant: G.D. Searle & Co.
    Inventors: Rajeev Gokhale, Martin J. Griffin, James E. Truelove, James C. Stolzenbach, Aziz Karim, Ajit K. Roy
  • Transdermal pentamidine
    Patent number: 5230897
    Abstract: Pharmaceutical compositions and transdermal patches comprised of pentamidine and a penetration enhancing amount of a terpene selected from the group consisting of menthol, carvone, carveol, dihydrocarveol, dihydrocarvone, neomenthol, isopulegol, terpene-4-ol, menthone, pulegol, camphor, geraniol, .alpha.-terpineol, citral, linalol, carvacrol, thymol and anethole are disclosed for delivery of a therapeutically effective amount of pentamidine or its pharmaceutically acceptable salts.
    Type: Grant
    Filed: October 31, 1991
    Date of Patent: July 27, 1993
    Assignee: G. D. Searle & Co.
    Inventors: Martin J. Griffin, Tugrul T. Kararli, Stanley C. Penzotti, Jr., Rachelle M. Rydzik, Cynthia M. Schmidt